Publication Name	World Journal of Rheumatology
Manuscript ID	10603
Country	United Kingdom

Received	2014-04-09 10:01
Peer-Review Started	2014-04-09 19:28
To Make the First Decision	2014-06-06 10:58
Return for Revision	2014-06-10 09:01
Revised	2014-06-21 03:40
Second Decision	2014-07-29 09:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-07-29 09:57
Articles in Press	2014-07-29 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-03 17:46
Publish the Manuscript Online	2014-09-12 13:58

ISSN	2220-3214 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Observational Study
Article Title	Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals?
Manuscript Source	Invited Manuscript
All Author List	Yasser El Miedany, Maha El Gaafary, Ahmed El Yassaki, Sally Youssef, Annie Nasr and Ihab Ahmed
Funding Agency and Grant Number
Corresponding Author	Yasser El Miedany, MD, FRCP, Consultant Rheumatologist, Darent Valley Hospital, Dartford, Kent, DA2 8DA, United Kingdom. miedanycrd@yahoo.com
Key Words	The World Health Organization fracture risk assessment tool; Osteoporosis; Fracture; Dual-energy X-ray absorptiometry
Core Tip	Treatment of osteoporosis should assure that the patient benefits from the treatment without experiencing undue harm. Monitoring of patients treated for osteoporosis has been recommended and so far dual-energy X-ray absorptiometry has been recognized as the tool to monitor osteoporosis therapy by several clinical practice guidelines. Recently, the duration of osteoporosis therapy became a research question with the possibility of having a drug holiday. However, more research is still needed to adequately assess when to stop the osteoporosis therapy and what is the optimal duration of the drug holiday. This work was carried out aiming at determining whether the World Health Organization fracture risk assessment tool can be used as a tool to monitor patients receiving osteoporosis treatment and to evaluate its ability to predict new low trauma fractures.
Publish Date	2014-09-12 13:58
Citation	El Miedany Y, El Gaafary M, El Yassaki A, Youssef S, Nasr A, Ahmed I. Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals? World J Rheumatol 2014; 4(2): 14-21
URL	http://www.wjgnet.com/2220-3214/full/v4/i2/14.htm
DOI	http://dx.doi.org/10.5499/wjr.v4.i2.14

Full Article (PDF)	WJR-4-14.pdf
Full Article (Word)	WJR-4-14.doc
Manuscript File	10603-Review.docx
Answering Reviewers	10603-Answering reviewers.pdf
Copyright License Agreement	10603-Copyright assignment.pdf
Peer-review Report	10603-Peer review(s).pdf
Scientific Misconduct Check	10603-CrossCheck.jpg
Scientific Editor Work List	10603-Scientific editor work list.pdf